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Abstract: Type 2 Diabetes Mellitus (T2DM) and Gestational Diabetes (GDM) are important 
and escalating problems worldwide. GDM increases the risk of complications in pregnancy 
and birth, as well as a 1 in 2 chance of developing T2DM later in life. The burden of GDM 
extends to offspring, who have an increased risk of obesity and diabetes—further 
perpetuating the cycle of diabetes within families. Clinical trial evidence demonstrates 
T2DM incidence reduced by up to 50% for women with GDM with nutrition and physical 
activity changes and the economic modeling suggests cost effectiveness. The key diet-related 
changes to reduce T2DM risk are reviewed, in addition to breastfeeding. The difficulties 
associated with the delivery of dietary and lifestyle behaviour change to women after GDM 
are discussed and focus on: complex healthcare system interactions needed for care delivery; 
women finding postpartum self-care challenging; and low levels of awareness being present 
across the board. In addition, studies currently underway to improve care provision in this 
important area will be examined. 
Keywords: gestational diabetes mellitus; lactation; postpartum; lifestyle modification; type 
2 diabetes mellitus; diabetes prevention 
 
  
OPEN ACCESS 
Healthcare 2014, 2 469 
 
1. Introduction 
The International Diabetes Federation (IDF) estimated that in 2013, 21.4 million or 16.8% of live 
births to women had “some form of hyperglycaemia in pregnancy” [1]. This is in the setting of rapidly 
increasing numbers of people diagnosed as having diabetes, and a projected rise of 55% by 2035 [1]. 
Diagnosed gestational diabetes (GDM) affects approximately 7% of pregnancies worldwide [2]. 
Furthermore, GDM incidence rates are increasing attributed mainly to rising population obesity levels [2]. 
In Australia by 2023, diabetes is estimated to be the largest contributor to the burden of disease [3] and 
by 2033, the economic burden is estimated to be $7 billion [4]. 
At least 17,000 Australian women are diagnosed with GDM every year [5] but this is most likely an 
under representation. Bullard et al. reported that the prevalence of prediabetes defined by fasting plasma 
glucose (FPG) and glycated haemoglobin A1c (HbA1c) in the US for their 18–44 year olds was 26% [6]. 
Extrapolating from the Hyperglycaemia and Adverse Pregnancy Outcome study, the overall rate of 
GDM was 16% and 13% in the two Australian Field Centres, Brisbane and Newcastle [7]. Hence, these 
data suggest that diagnostic rates less than 10% are likely to be missing women (and their offspring) at 
significant risk of adverse pregnancy outcomes due to hyperglycaemia. Applying the new International 
Alliance of Diabetes in Pregnancy Society Guidelines/World Health Organisation diagnostic criteria [8,9] to 
the most recent Australian census data (in 2011 there were 301,620 live births), over 54,000 women—1 in 6 
pregnancies—would be identified with GDM annually. While this figure on its own presents an 
enormous challenge for maternity services, it is evident that it will also have substantial knock-on 
increases in pathology testing and further strain on the already constrained primary care sector. 
GDM is the single strongest population predictor of T2DM development and there is at least a seven 
fold increase in T2DM in women who have had GDM compared to those with euglycemic pregnancies [10]. 
Those who have had GDM during one pregnancy have 30%–50% risk of developing GDM in another 
pregnancy [11,12] and the GDM pregnancy and birth itself will have an increased risk of complications 
for both mother and baby [13]. Moreover, women with a history of GDM are at increased risk of 
cardiovascular disease (CVD) [13,14] and the burden of GDM extends to their offspring, who 
themselves have an increased risk of obesity and diabetes [15,16]—further perpetuating and potentially 
expanding the cycle of diabetes within families. 
In the face of this growing tide of T2DM coming from women who have had GDM, a healthcare 
chasm has begun to surface because the majority of women who have had GDM are not being screened 
regularly [17,18] nor receiving consistent diabetes prevention care [11,19,20]. This chasm has been 
subject to a recent call to action by the National Diabetes Education Program and American College of 
Obstetricians and Gynecologists, asking primary care providers to better meet the needs of this group of 
women [21]. Taking the call to action on-board along with a recent Australian call [22], this review will 
focus on the primary care sector and examine the issues surrounding current best practice guidelines for 
postpartum diabetes prevention. The review will investigate the core behaviour change areas within the 
guidelines, namely lifestyle modification and the importance of breastfeeding. In addition, it will look 
at new studies currently underway that seek to translate the evidence into improved provision of care to 
this population.  
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2. Best Practice Guidelines for Diabetes Prevention in Women Who Have Had GDM 
Evidence-based care requires evidence-based intervention [23], which necessitates strategies that 
improve the uptake and use of clinical practice guidelines by the intended guideline audience [24]. 
Recommendations for the prevention of T2DM within different population subgroups exist around the 
world. They are typically the result of inputs from professional bodies and organisations, where they 
seek to digest the available evidence into a format that will result in improved quality of care after careful 
consideration of the strength and applicability of research findings. However, a common problem with 
best practice guidelines is that several exist for a single health condition or care delivery setting which 
can result in healthcare practitioner inactivity due to the lack of consistent guidance. 
There are three main Australian guidelines circulating for the follow-up of women at risk of diabetes 
(Australian Diabetes in Pregnancy Society (ADIPS) [25], Therapeutic Guidelines Limited [26] and 
Guidelines for Preventative Activities in General Practice [27]) but unfortunately they lack a consistent 
approach for GDM follow-up care (Table 1). All three guidelines are inconsistent with the current NICE and 
American Diabetes Association guidelines [28,29] so while GPs recognise the importance of follow-up [19] 
and the variety of professionally endorsed options arguably gives them a broader set of clinically valid 
alternatives, the level of choice may paradoxically leave them feeling more exposed to risk [30,31]. In a 
recent Australian study, GPs involved in shared maternity care reported awareness and usage of a wide 
variety of guidelines [32]. While these GPs are not representative of the broader GP community and as 
a group their care provision should be a model of best practice, even this group was not adhering to the 
lifestyle modification guidance [32]. A large UK survey of primary and secondary care providers 
reported the sole national NICE guideline was not consistently being adhered to [33] so while having 
several guidelines is a possible issue, it is certainly not the only barrier to better care provision. 
A diagnosis of GDM will typically result in a mother being defined as a higher risk pregnancy and as 
such, her care will be moved from any GP or midwife care to a specialist consultant and hospital-based 
care arrangement. However, once a mother is discharged from maternity services, the continuity of her 
care can be disrupted particularly in relation to her GP-led postnatal GDM care. Health care providers 
typically report issues around these women being lost to follow up and a lack of continuity of care 
existing [20,33,34] and this sentiment is also echoed in women [20,35,36]. Research into improving 
continuity of care is challenging because of the different healthcare systems and how they operate. One 
systems level change initiated is the Australian National Gestational Diabetes Register (commenced July 
2011), the first national registry of women with GDM that works across healthcare systems. A woman’s 
registration commences in pregnancy and the registry delivers annual reminders to them and their health 
care providers about the importance of screening and a healthy lifestyle [37]. 
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Table 1. Guidelines for postnatal diabetes prevention care of women who have had gestational diabetes. 
Guideline Topic RACGP [27] TG Ltd. [26] ADIPS [25] NICE [28] ADA [29] 
Postnatal screening  
6–12 weeks after 
delivery; OGTT 
6–12 weeks after 
delivery; 75 g OGTT 
6–12 weeks after 
delivery; OGTT 
6 weeks after delivery; 
FPG 
6–12 weeks after 
delivery; 75 g OGTT 
Repeat screening 3 Yearly 
Yearly (Alternatively 
75 g OGTT every 2 
years or if 
contemplating further 
pregnancy) 
Yearly; OGTT if 
contemplating further 
pregnancy 
Yearly 
1–3 Yearly; yearly if 
IFG or IGT, otherwise 
3 yearly 
Repeat screening test  FPG FBG or RBG 75 g OGTT or FPG FPG 75 g OGTT 
Lifestyle 
recommendations 
General healthy eating 
Increase physical 
activity (30 min brisk 
walking 5 days a week) 
and/or weight loss. 
Encourage 
breastfeeding 
Healthy diet and 
exercise 
Weight control 
Healthy diet and 
exercise 
Weight control 
Healthy diet and 
exercise 
Encourage 
breastfeeding 
Weight loss 7% body 
weight 
Low fat 
Increase fibre at  
14 g/1000 kcal and 
whole grains 
Increased PA to  
150 min/week moderate 
activity 
IFG = Impaired Fasting Glucose, IGT = Impaired Glucose Tolerance, FPG = Fasting Plasma Glucose, FBG = Fasting Blood Glucose, RBG = Random Blood Glucose, 
OGTT = Oral Glucose Tolerance Test. 
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Postpartum Screening for Type 2 Diabetes 
T2DM screening rates are low for women with a history of GDM [34,38] and there are several reasons 
why this is occurring. Recent Australia data for Queensland shows the estimated probability of women 
receiving any diabetes screening test within the first three years postpartum to be 49% and this drops to 
34% for the oral glucose tolerance test (OGTT) [17]. Early infancy is a busy time for mothers—their 
own health tends to be neglected—with women citing time pressures, dislike of testing procedures, 
inconvenience and lack of childcare as barriers to screening [19,20,38,39]. General practitioners on the 
other hand report being undecided on which blood test to use [11,12,20,40]. Several guidelines 
recommend fasting blood glucose because the gold standard OGTT is so time-consuming, yet other 
guidelines recommend it [25–27,41]. A similar predicament is presented to GPs when they seek to find 
out what is the ideal time point to repeat a woman’s screening test—spacing varies from one to three 
years [25–27,41]. An additional complexity surrounds the use of HbA1c to diagnose diabetes, HbA1c is 
recommended as a suitable test to diagnose diabetes [29] but the guidelines for women who have had 
GDM do not yet endorse it even though HbA1c would present a much more appealing annual screening 
option for busy mothers as it is a non-fasting test [25,42]. The barrier in Australia to HbA1c being used is 
that currently reimbursement by Medicare can only happen when the person has diagnosed diabetes [43]. 
Given the spread of these practical issues, it is not surprising that systematic screening is not  
happening [22,32]. 
Attendance rates for screening are consistently low for women with a history of GDM, ranging from 
35% to 56% [10,11,34,44]. Four potential strategies have been put forward to increase the rates of 
screening amongst women with a history of gestational diabetes based on the evidence: simplify  
testing [18,38]; increase awareness across the board [19,38,45]; improve organisation of care [40]; and 
set-up automatic reminders (GPs and women) [18,19,46–48]. While all of the strategies have been used 
to good effect in women postnatally, the main problem is delivering them together in a coordinated 
manner within primary care settings [20,22,49]. A simplified care plan (Figure 1) has been developed 
for women with GDM, the flowchart starts with the initial postnatal period and incorporates several of 
the strategies mentioned above into the care process and uses guideline-led care to map out what a more 
coordinated approach might look like in practice. 
3. Type 2 Diabetes Prevention 
Clinical trials demonstrate T2DM incidence reduced by up to 58% for high risk people following 
lifestyle change [50–52] and economic modeling suggests lifestyle modification programs are cost 
saving or very cost effective [53,54]. The US Diabetes Prevention Program (DPP) provided evidence 
that lifestyle change works for women post-GDM, their T2DM risk reduced by 50% [55] and the effect 
of diabetes prevention continued 10 years after the intervention within the whole DPP cohort [56]. All 
three large lifestyle modification studies have been able to show sustained reduction in conversion to 
T2DM (though not specifically in women who have had GDM), ranging from 34% at 10 years [56] 
through to 43% at 7 years [57] and 20 years [58]. Therefore, addressing GDM constitutes a window of 
opportunity for early intervention and reduction of the future burden of T2DM. 
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Figure 1. Postnatal management for women who have had gestational diabetes. Simplified 
care plan within a flowchart for a woman with a Gestational Diabetes (GDM) pregnancy 
based on guidelines. The creation of a register within a GP practice will enable recall and 
reminders at appropriate time points. Abbreviations: HbA1c (glycated haemoglobin A1c); 
GP (general practitioner); GDM (gestational diabetes); OGTT (oral glucose tolerance test); 
IGT (impaired glucose tolerance); IFG (impaired fasting glucose); BMI (body mass index); 
FPG (fasting plasma glucose); and T2DM (type 2 diabetes). 
 
DPPs have traditionally been designed to meet the needs of an older population at risk of developing 
diabetes, the mainstay of clients attending programs. However, women who have had GDM are younger 
and will typically have different life stage issues as a result. Those differences become important when 
considering the design and delivery of a DPP for this population. Looking at qualitative work in this area 
shows that issues include: provision of childcare for attendance; accessibility of the venue (feeding 
facilities and pram access); fitting DPP attendance into busy family life; needing a family-friendly 
lifestyle modification; and affordability of the DPP [20,59–62]. There is currently a large Canadian 
prospective cohort study seeking to further elucidate this within a multiethnic group [63] as the previous 
Normal BMI BMI ≥25 
Healthy eating and physical 
activity advice 
Healthy weight advice (5%–7% 
weight loss) 
Annual FPG (or HbA1c) 
T2DM Normoglycaemic 
Woman on GP practice GDM register 
Initial postnatal OGTT (6–12 weeks) 
T2DM IGT or IFG Normoglycaemic 
Diabetes management 
plan 
Diabetes risk assessment 
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work has been within small groups of women and it is important to know which barriers hold across the 
broader GDM population and are important considerations for larger scale DPPs. 
3.1. Risk Awareness 
Perception of risk is important to motivate women for both follow-up testing and uptake of lifestyle 
modification messages [64]. Despite understanding the association between GDM and T2DM, women 
with GDM do not perceive themselves to be at elevated risk [19,36,64]. The lack of perceived self-risk 
of developing T2DM is common in women [34,64,65] and awareness amongst health professionals and 
the general public of GDM’s risk is also low [19,66]. A systematic review of diabetes care in the primary 
care setting found that health outcomes improve for consumers if personalised risk communication and 
communication before consultations are provided [67]. FINDRISC [68] and AUSDRISK [69] are 
examples of tools that could potentially be used to initiate risk communications within the primary care 
setting for women with a history of GDM. 
3.2. Lifestyle Modification 
The evidence around lifestyle modification shows a definite and maintained decrease in progression 
to T2DM in a variety of populations [50,52,55,70–73]. While there is uniform agreement that lifestyle 
modification is warranted to prevent diabetes, the way in which that message is communicated varies 
between guidelines (Table 1) leaving room for difference in interpretation by caregivers and the women 
themselves [20]. The guidelines for physical activity are relatively consistent but it is the area of nutrition 
where difference is more evident. 
Women of childbearing age will typically see their GP 12 times in a year—making them the 
healthcare professional most regularly contacted during that period [74]—and a logical setting for care 
provision and/or coordination. GPs are also the main source of nutrition care in the primary care setting—
discussing nutrition concepts in ~7% of consultations—equating to over 7.9 million occurrences per year 
in Australia [75]. This finding is likely to be more reflective of limited access to dietitians, with expertise 
in the delivery of lifestyle modification, rather than patient preference due to issues such as distance, 
cost, lack of awareness or availability affecting choice [76]. Within the above context, the GP and 
practice staff become the resource that women will typically use to support their engagement in diabetes 
prevention, alongside any available community-based public health programs [77]. Systematic review 
validates GP capacity to provide nutrition care that enhances nutrition behaviour and risk factors in 
individuals with lifestyle-related chronic disease [78] and that advice from GPs can be a powerful 
motivator for women to adopt lifestyle modification [79,80]. However, the evidence points to GPs 
needing more training in the delivery of lifestyle advice—particularly nutrition advice—for diabetes 
prevention [20,81,82]. Shortfalls in nutrition knowledge are the likely reason for GPs stating reduced 
confidence and self-perceived ability in delivering nutrition care [81,83], even though they report strong 
positive attitudes on the importance of providing nutrition care to patients with chronic disease [81,82]. 
Evidence for the effectiveness of nutrition care in general practice, particularly in relation to GDM, is 
unclear as a result and indicates that further support is needed for GPs to provide diabetes prevention-relevant 
lifestyle advice to patients [20,84] and that GPs will typically be more comfortable coordinating a 
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women with a history of GDM’s care and monitoring her health markers than delivering specific lifestyle 
advice [32]. 
3.2.1. Weight Loss 
Weight loss is thought to be the risk factor that explains the greatest variance in risk and the one that 
is most amenable to change [85]. Maternal pre-conception weight has been increasing in line with 
population gains [86]. We know that in a large recent study of over 22,000 women, mothers who gained 
over 3 kg/m2 between pregnancies had 3.4 times higher odds of developing T2DM [87]. Even a 1–2 kg/m2 
maternal gain resulted in 1.7 raised T2DM odds but the positive message was, mothers who were 
overweight at their index pregnancy and subsequently lost around 2 kg/m2 decreased their risk by almost 
80% [87]. It is not simply weight gain after delivery that is clinically relevant but also weight gain during 
and after pregnancy [88]. Peters et al. demonstrated that for every 4.5 kg weight gained after delivery 
there was a doubling in risk for T2DM development, even after adjustment for OGTT results, post natal 
BMI and breastfeeding [89]. 
As with all lifestyle interventions, successful weight loss is difficult to achieve. The Diabetes 
Prevention Program’s GDM arm achieved 7% weight loss, which resulted in a 53% reduction in T2DM 
incidence [55]. However, the mean weight loss of women with a history of GDM was only 1.6 kg at 3 years 
(3.5 kg regain) compared to 4 kg mean weight loss for women in the DPP without GDM [55]. Within 
diabetes prevention studies the relative risk reduction for T2DM development is 16% for each kilogram 
lost [90] but weight regain is also well documented [56] and thought to happen due to the body’s 
physiologic drive to return to the original higher weight [91] and a whole raft of psychosocial barriers [20]. 
However, a simple effective tool in supporting weight management and long-term weight loss is  
self-monitoring [92–94] and this can be readily incorporated into the care of women with a history of GDM. 
3.2.2. Macronutrients 
Apart from weight loss, the composition of the diet is important in GDM and T2DM prevention. 
Within the Diabetes Prevention Program, the reduction of energy from fat and increased levels of 
physical activity were predictive and contributed to sustained weight loss [90]. The Finnish Diabetes 
Prevention Study had additional dietary targets outside weight loss and increased physical activity from 
the Diabetes Prevention Program that were: less than 30% energy from fat; less than 10% energy from 
saturated fat; and more than 15 g dietary fibre per 1000 kcal [95]. While the only significant association 
for diabetes risk in the intervention was weight loss, the authors proposed the dietary composition and 
physical activity were important but mediated their effects through weight reduction [57]. 
Dietary patterns that align with the Finnish Diabetes Prevention Study dietary targets have been 
associated with decreased risk of diabetes among women who have had gestational diabetes, although 
such studies are few. A Korean study looked at dietary composition postnatally (6–12 weeks) and found 
a greater saturated fat intake and a higher ratio of fat to total energy was associated with diabetes and 
pre-diabetes [96]. 
The Nurses’ Health Study II cohort is the main dataset used for prospective studies exploring 
associations in women and pregnancy. Dietary fibre and glycaemic index were explored for associations 
with GDM occurrence and the main outcome was that for every 10 g/day total fibre increase there was 
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a 26% reduction in GDM risk (95% CI 9–49) [97]. In a recent Nurses Health Study cohort, 4413 women 
with histories of GDM were followed over 14 years and had their dietary patterns assessed at 4 yearly 
intervals; women’s dietary patterns were scored by several scales based on the Mediterranean diet, 
Dietary Approaches to Stop Hypertension (DASH) diet and the Healthy Eating Index [98]. Women 
consuming diets within the highest quartile for the Mediterranean diet scale had 40% lower T2DM risk 
compared with those in the lowest quartile (hazard ratio 0.60, 95% CI 0.44–0.82). Similar risk reductions 
were seen for the DASH diet (46% lower risk, hazard ratio 0.54, 95% CI 0.39–0.73) and Healthy Eating 
Index (57% lower risk, hazard ratio 0.43, 95% CI 0.31–0.59) [98] even after multiple adjustments (age, 
total calorie intake, age at first birth, parity, ethnicity, parental diabetes, oral contraceptive use, 
menopause, and smoking) but the risk reduction was partially mediated by body mass changes. In a 
subsequent study, 21,411 singleton pregnancies were identified prospectively over a 10 year period and 
low carbohydrate dietary patterns analysed against GDM development [99]. Women with a pre-pregnancy 
low-carbohydrate dietary pattern with high animal food sources of saturated fat and protein and fat from 
animal-food sources were at significantly more risk of GDM development but those with a low-carbohydrate 
and high vegetable food sources were not at a raised risk [99]. 
3.2.3. Physical Activity 
The message on physical activity within guidelines for women with a history of GDM is relatively 
consistent. However, the evidence to support the benefit of physical activity in preventing diabetes in 
these women comes mainly from the China Diabetes Prevention Study [52] and there has been some 
doubt cast over the quality of the data [100]. However, Bao et al. recently showed women who have had a 
GDM pregnancy within the Nurses Health Study II cohort had a 9% risk reduction for T2DM 
development (adjusted relative risk 0.91; 95% CI, 0.88–0.94) for every 100 minutes of moderate 
intensity physical activity they had, which remained significant after BMI adjustment. Importantly, 
women who increased their physical activity by 150 minutes moderate intensity per week compared to 
those who maintained their physical activity level were 47% less likely to develop T2DM (RR, 0.53; 
95% CI, 0.38–0.75); again the association remained significant after BMI adjustment [101]. Conversely, 
high levels of sedentary behaviours such as screen time were associated with increased risk [101] making 
both sides of the physical activity equation important considerations. 
3.3. Breastfeeding 
Breastfeeding is known to provide numerous health benefits to both mother and baby. For mothers 
who have a history of GDM, improved lipid and glucose metabolic profiles during the first 3 months 
following delivery are reported but the downside is that they breastfeed for a shorter length of time and 
are less likely to start breastfeeding in the first place [102]. Longer term good quality studies found 
breastfeeding for >3 months decreased the risk of T2DM by >40% (HR 0.54, 95% CI 0.34–0.85) after 
adjusting for islet autoantibodies, family history of diabetes, maternal BMI, age, and smoking [103] and 
breastfeeding for >10 months improved glucose tolerance, and increased insulin sensitivity and insulin 
secretion/insulin sensitivity [104]. Ziegler et al. also found in their prospective study that breastfeeding 
for ≥3 months delayed T2DM onset by 10 years compared with <3 months breastfeeding [103]. It is also 
Healthcare 2014, 2 477 
 
worth noting that the reduction in risk did not appear to be entirely mediated through weight because 
change in weight postnatally and length of breastfeeding were not significant [103]. 
The awareness levels of mothers around the benefits of breastfeeding for their babies is generally 
high, however the benefits to their own long-term health is frequently overlooked when they are 
receiving education. It is now apparent that breastfeeding can prevent metabolic syndrome [105] and 
preserve beta cell function [104] as well as improved postnatal weight loss, reduced obesity [102] and 
T2DM risk [103]. A mother’s decision to commence and continue to breastfeed is normally based on 
the benefits her baby will receive but it is essential for women who have had GDM to receive education 
from their healthcare providers on the health benefits to their own health and receive adequate 
breastfeeding support [102]. Considering the typical demographic of women with GDM coming from 
lower socioeconomic backgrounds, breastfeeding offers a safe and low-cost intervention to prevent 
T2DM development. 
Successful breastfeeding is dependent on effective lactogenesis occurring during both lactation stages 
(stage 1: early colostrum production and stage 2: increased milk volume production between 36 h and 92 h 
post-partum). Matias et al. recently reported a third of women with GDM in a prospective cohort study 
having delayed onset of stage 2 lactogenesis [106], the risk factors associated with that delay being 
maternal obesity (OR 1.56, 1.07–2.29 95% CI), insulin treatment (OR 3.11, 1.37–7.05 95% CI) and 
suboptimal in-hospital breastfeeding support (OR 1.65, 1.20–2.26 95% CI) [106]. The associations 
between maternal obesity and lower rates of breastfeeding initiation are supported by other studies [107,108] 
and while breastfeeding initiation is not normally managed in primary care, incorporating advice into 
pre-conception counseling would be potentially beneficial for women. 
4. Intervention Programs 
With the increasing recognition of the importance of postnatal care in women who have had  
GDM [21,22], the level of research interest in improving the quality of that care has grown. High quality 
randomised controlled trial (RCT) data are needed to understand what constitutes an effective DPP in 
this population. There are several studies currently underway with the aim of developing feasible and 
effective programs to reduce T2DM risk in this population (Table 2). While not an intervention study, 
information on the impact of health beliefs, social support and self-efficacy on postnatal physical activity 
and dietary habits of women with GDM [109] will be reported in 2015. The study should allow 
development of a predictive theoretical model to optimise interventions in women who have had GDM, 
as it will be following a large cohort of 200 women prospectively and build on information gleamed 
from smaller qualitative datasets. 
The OGTT, as discussed previously, is a problematic test within this population but the clinical 
benefit of using it in women who have had GDM means that alternative strategies need to be investigated 
to improve compliance so as to maximize screening rates. The DIAMIND study is an RCT being trialed 
to improve screening rates through the use of SMS text message reminders [110] It plans to build on the 
evidence that reminders are an effective tool in increasing screening rates [20] and will use SMS’s at 6 
weeks, 3 and 6 months to encourage OGTT testing during the first 6 months post-partum versus SMS 
reminder only at 6 months in the control group. The outcome measure for DIAMIND will be the 
difference in OGTT screening rates between groups. 
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Debate exists about the most effective time point to intervene with a DPP in this population and as a 
result, interventions registered have either a postnatal-only [111–114] or a mixed approach that includes 
pregnancy and the postnatal period [115–118]). The mixed approach proposes that commencing 
education while a mother is pregnant builds on the healthy habits developed through intensive 
management of her GDM and a mother’s motivation to look after the wellbeing of her infant [115]. 
However, the postnatal only approach would argue that it can be problematic to translate into practice 
where distinct divisions between maternity and primary care services exist [119,120] and that women 
report the postnatal period to be a better time to start a DPP (where the focus is on their own health, not 
that of their infant) [62]. It remains to be seen which time point is more effective but the outcomes will 
most likely point to a tailored DPP approach for individual healthcare systems being the most beneficial. 
The results from DPP interventions have been few to date. Dulce Mothers reported earlier this year [113] 
on a translated US DPP for low income Latina women with a history of GDM. The study had a pre-post 
test design for the 8-week peer-led group education program. Dulce Mothers found a significant decrease in 
total cholesterol, LDL-cholesterol and triglycerides for the intervention but no change in body weight 
and a significant increase in HbA1c [113]. The lack of a control arm alongside the short 3-month follow-up 
period and some methodological concerns effectively limits the conclusions that can be drawn from the 
study. A pilot RCT of a phone-based lifestyle education program using motivational interviewing of 38 
Australian women demonstrated significant changes to total fat intake, leisure time physical activity and 
body mass index but this was also limited by the sample size [121]. The DEBI study was a pilot RCT 
that reported early promising results [122,123] and it has subsequently been scaled up to a larger RCT 
intervention, the GEM study [115]. DEBI randomized 197 women to receive a telephone and face-to-face 
delivered DPP with additional breastfeeding support during the woman’s pregnancy and postnatally 
versus usual care. The pilot found a significant decrease in dietary fat (−3.6%, p = 0.002) and changes 
that were close to significant for weight loss and increased breastfeeding [123] and a sub-group analysis 
showed women who lost >2 kg had improved glucose metabolism over those who maintained or gained 
weight [122]. 
Within the interventions where results are pending (Table 2), the key variance appears to be the level of 
intensity of contact with women and the mode of contact. The majority of the studies taking an individual 
approach are intensive and require around 13–20 contact sessions with each woman [115,117,123,124]. The 
lower end of the contact spectrum (~6 contacts) tend to use group settings to bring in peer interactions, 
which is a known enabler to change in this population [20] and a core component of the main DPPs [77]. 
The modes of contact typically involve face-to-face contact but some interventions are augmenting this 
traditional mode with SMS texts [110,116], telephone and/or print communications [111,112,115,117] 
as a way of reducing costs but also reflecting the common barrier reported by mothers of insufficient 
time to engage in behaviour change [20,62]. There are several interventions that plan on examining 
health economic and fidelity measures within the RCT [111,112,115,125] and these will be critical in 
the research translation process as they will enable greater uptake of the findings into areas like policy 
and practice due to their external validity. The ability to analyse the findings of the interventions within 
a systematic review and suitable meta-analysis will give healthcare providers and policy makers valuable 
information about effective ways to work with women who have had GDM to make lifestyle 
modifications and reduce their risk of T2DM. 
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Table 2. Registered lifestyle interventions to reduce type 2 diabetes risk in women who have had gestational diabetes. 
Study Title 
Recruitment 
Target 
Intervention 
Follow Up 
Duration 
Primary Outcome 
Measures 
Estimated 
Completion 
Mothers After 
Gestational Diabetes in 
Australia study 
(MAGDA) [111,112] 
574 Australian 
women 
(Victoria and 
South 
Australia) 
1 individual session and 5 group sessions  
(initial 3 months) and 2 follow-up telephone sessions. 
5 goals: 5% weight reduction, <30% energy from fat, 
<10% energy from saturated fat, 15 g fibre/ 1000 kcal, 
>30 min daily moderate or vigorous exercise. 
1 year 
Diabetes risk (FPG, 
weight or waist 
circumference) 
2015 
Tianjin Gestational 
Diabetes Prevention 
Program  
(TGDPP) [114] 
1180 Chinese 
women 
(Tianjin 
province) 
5 individual consults with dietitian (year 1) and  
2 individual consults with dietitian (year 2). 
6 goals: 5%–10% weight reduction in overweight women 
through > 10% reduction in total energy, <30% energy 
from fat, <10% energy from saturated fat, 55%–65% 
energy from carbohydrate, 20–30 g per day fibre, >30 min 
daily moderate or vigorous exercise. 
2 years Incident T2DM 2013–2014 
The DIAMIND  
study [110] 
276 Australian 
women (South 
Australia) 
SMS text OGTT reminder at 6 weeks postpartum, with 
further reminders at 3 and 6 months if not tested. Control 
group receive single SMS text reminder at 6 months 
postpartum. 
6 months 
OGTT attendance 
by 6 months  
post-partum 
2014 
Lifestyle Intervention 
Program for Women 
With Gestational 
Diabetes or Gestational 
Impaired Glucose 
Tolerance  
(APPLES) [124] 
350 American 
women 
(California) 
1 individual session and 3 telephone counseling sessions 
(Phase 1, during pregnancy). After 6 weeks post-partum,  
3 individual sessions and 13 telephone counseling 
sessions (phase 2, 6 months). 
DPP goals (weight reduction and increased physical 
activity). 
2 years 
Achievement of 
pre-pregnancy 
weight if normal 
BMI pre-pregnancy 
or 5% weight 
reduction on pre-
pregnancy weight if 
overweight 
2016 
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Table 2. Cont. 
Study Title 
Recruitment 
Target 
Intervention 
Follow Up 
Duration 
Primary Outcome 
Measures 
Estimated 
Completion 
Croí MyAction  
program [125] 
54 Irish 
women 
(Galway) 
1 individual risk assessment and 2.5 h session weekly for 
12 weeks (1 h group exercise, 1 h group education and 
30min individual session). Support person participates in 
12-week program. Goals: BMI >30 kg/m2, >30 minutes 
moderate intensity physical activity >5 days per week, 
Mediterranean dietary pattern. 
1 year 
Mean FPG 
reduction on OGTT 
2014 
Optimizing Outcomes in 
Women with Gestational  
Diabetes Mellitus and 
their Infants study [116] 
100 American 
women (North 
Carolina) 
Phase 1 (4 months): 1 group session (during pregnancy) 
and 13 group sessions (post-partum, includes 1 h exercise 
class). Phase 2: 3 group sessions at monthly intervals. 
Weekly SMS text from enrollment to study completion. 
10 months 
FBG and weight 
(BMI) 
2014 
Dulce Mothers [113] 
84 Latina 
American 
women 
(California) 
8 weekly 2 h group sessions including 15–20 minutes 
exercise. 
DPP goals (weight reduction and increased physical 
activity). 
6 months 
HbA1c, blood 
lipids and weight 
(BMI) 
2014 
(completed) 
Estudio Parto [117] 
300 Hispanic 
American 
women 
(Massachusetts) 
Phase 1: 1 individual session (during pregnancy),  
1 individual session (6 weeks post-partum), 
weekly/fortnightly/monthly print and telephone contact  
(6 months). Phase 2: monthly/bimonthly print and 
telephone contact (6 months) 
1 year 
Weight (BMI), 
insulin resistance 
markers and 
cardiovascular 
disease risk 
markers 
2016 
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Table 2. Cont. 
Study Title 
Recruitment 
Target 
Intervention 
Follow Up 
Duration 
Primary Outcome 
Measures 
Estimated 
Completion 
Gestational Diabetes’ 
Effects on Moms (GEM) 
study [115] 
2320 
American 
women 
(California) 
Phase 1: Individual weight goal letter (during pregnancy). 
Phase 2: 13 telephone sessions and support materials  
(6 months). Phase 3: 3 newsletters and support materials 
(6 months) 
1 year 
Achieving  
post-partum weight 
goal and total 
weight change 
2014 
Prevention of gestational 
diabetes through 
lifestyle modification 
(RADIEL)  
study [118] 
728 Finnish 
women (South 
Eastern 
region) 
Individual counseling 3 monthly pre and during 
pregnancy and at 6 weeks, 6 months and 12 months. 
Goals: 5%–10% weight loss pre-pregnancy if BMI  
≥25 kg/m2 or no weight gain during first 2 trimesters for 
pre-pregnancy BMI ≥30 kg/m2, >30 min daily moderate 
or vigorous exercise, 1600–1800 kcal/day, 40%–50% 
energy from carbohydrates, 30%–40% from fats and 
20%–25% from protein. 
1 year OGTT 2014 
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5. Conclusions 
Gestational diabetes presents us with a tantalising challenge. We know women who develop GDM 
are at high risk of developing T2DM, yet what remains outside our grasp is how to effectively translate 
the prevention information into practice. The screening process enables us to identify women at risk and 
start prevention measures earlier but there are issues surrounding engaging women and their healthcare 
providers such as GPs in the process over time. There is recognition amongst professional representative 
bodies that diabetes prevention within this sub-group of the population is important. However, the 
variance between guidelines from these bodies is not conducive to a universal approach to care delivery. 
The translation of the key lifestyle components into effective evidence-based practice needs to 
overcome numerous implementation barriers. The proposed solutions to those barriers being: effective 
prevention program development; evidence-based care delivery by GPs; system level change to improve 
transfer and monitoring of medical information; awareness raising of GDM as a diabetes predictor; 
alongside environmental and social supports to promote healthy eating and physical activity. If those 
implementation dominos were to line up, what we would see would be an evidence-to-practice bridge 
being formed with the risk of diabetes fading for women who have had GDM and a healthier future for 
them and their families. However, there is still plenty of work to be done and the outcomes of several 
forthcoming intervention studies should help shine some light on the paths we need to follow. 
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